account_balance
Investment manager · 13F filer · SEC CIK 1674712
Vivo Capital, LLC
Reported value$1.1Bas of Jun 30, 2026
Positions47 8 new, 6 sold out
Top 10 weight52.4%TRVI alone is 9%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
TRVITrevi Therapeutics Inc
8.7%
PRAXPraxis Precision Medicines
8.3%Trimmed −20%
ERASErasca Inc
6.9%Trimmed −66%
AVBPArrivent BioPharma Inc
5.3%Added +90%
ABVXAbivax SA - ADR
5.0%Added +73%
TNGXTango Therapeutics Inc
3.9%Trimmed −36%
CRVSCorvus Pharmaceuticals Inc
3.8%
DRUGBright Minds Biosciences Inc
3.6%
Sinovac Biotech Ltd.
3.5%
TENXTenax Therapeutics Inc
3.3%Added +1100%
ACRSAclaris Therapeutics, Inc.
3.2%
DYNDyne Therapeutics Inc
3.2%
TRVITrevi Therapeutics Inc
8.7%
PRAXPraxis Precision Medicines
8.3%Trimmed −20%
ERASErasca Inc
6.9%Trimmed −66%
AVBPArrivent BioPharma Inc
5.3%Added +90%
ABVXAbivax SA - ADR
5.0%Added +73%
TNGX3.9%CRVS3.8%DRUG3.6%Sinovac Biotech Ltd.3.5%
TENX3.3%ACRS3.2%DYN3.2%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
TRVI Trevi Therapeutics Inc 8.7% HeldPRAX Praxis Precision Medicines 8.3% Trimmed −20%ERAS Erasca Inc 6.9% Trimmed −66%AVBP Arrivent BioPharma Inc 5.3% Added +90%ABVX Abivax SA - ADR 5.0% Added +73%TNGX Tango Therapeutics Inc 3.9% Trimmed −36%CRVS Corvus Pharmaceuticals Inc 3.8% HeldDRUG Bright Minds Biosciences Inc 3.6% Held
Sinovac Biotech Ltd. 3.5% Held
TENX Tenax Therapeutics Inc 3.3% Added +1100%ACRS Aclaris Therapeutics, Inc. 3.2% HeldDYN Dyne Therapeutics Inc 3.2% HeldWhat changed